Enzon Pharmaceuticals buy DomRuinart
Start price
01.12.20
/
50%
€0.12
Target price
01.12.21
€0.000
Performance (%)
49.17%
End price
14.12.20
€0.18
Summary
This prediction ended on 14.12.20 with a price of €0.18. With a performance of 49.17% the BUY prediction by DomRuinart was a big success. DomRuinart has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Enzon Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
According to DomRuinart what are the pros and cons of Enzon Pharmaceuticals for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread Enzon Pharmaceuticals diskutieren
Buy mit Kursziel 0,0